Evidence map›Paper›PMID 25596735›Full record

ArticleOncotarget2015

Carnosic acid sensitized TRAIL-mediated apoptosis through down-regulation of c-FLIP and Bcl-2 expression at the post translational levels and CHOP-dependent up-regulation of DR5, Bim, and PUMA expression in human carcinoma caki cells.

Kyong-Jin Jung, Kyoung-jin Min, Jae Hoon Bae, Taeg Kyu Kwon

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. The "Janus" Role of C/EBPs Family Members in Cancer Progression.International journal of molecular sciences · 2020
    Review
  18. Anticancer Activity ofNutrients · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kyong-Jin JungDepartment of Immunology, School of Medicine, Keimyung University, Daegu 704-701, South Korea.
Kyoung-jin MinDepartment of Immunology, School of Medicine, Keimyung University, Daegu 704-701, South Korea.
Jae Hoon BaeDepartment of Physiology, School of Medicine, Keimyung University, Daegu 704-701, South Korea.
Taeg Kyu KwonDepartment of Immunology, School of Medicine, Keimyung University, Daegu 704-701, South Korea.
Keimyung University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carnosic acid is a phenolic diterpene from rosmarinus officinalis, and has multiple functions, such as anti-inflammatory, anti-viral, and anti-tumor activity. In this study, we examined whether carnosic acid could sensitize TRAIL-mediated apoptosis in human renal carcinoma Caki cells. We found that carnosic acid markedly induced TRAIL-mediated apoptosis in human renal carcinoma (Caki, ACHN, and A498), and human hepatocellular carcinoma (SK-HEP-1), and human breast carcinoma (MDA-MB-231) cells, but not normal cells (TMCK-1 and HSF). Carnosic acid induced down-regulation of c-FLIP and Bcl-2 expression at the post-translational levels, and the over-expression of c-FLIP and Bcl-2 markedly blocked carnosic acid-induced TRAIL sensitization. Furthermore, carnosic acid induced death receptor (DR)5, Bcl-2 interacting mediator of cell death (Bim), and p53 up-regulated modulator of apoptosis (PUMA) expression at the transcriptional levels via CCAAT/enhancer-binding protein-homologous protein (CHOP). Down-regulation of CHOP expression by siRNA inhibited DR5, Bim, and PUMA expression, and attenuated carnosic acid plus TRAIL-induced apoptosis. Taken together, our study demonstrates that carnosic acid enhances sensitization against TRAIL-mediated apoptosis through the down-regulation of c-FLIP and Bcl-2 expression, and up-regulation of ER stress-mediated DR5, Bim, and PUMA expression at the transcriptional levels.

Indexed as

AbietanesAnimalsAntineoplastic Combined Chemotherapy ProtocolsApoptosis Regulatory ProteinsBcl-2-Like Protein 11Breast NeoplasmsCarcinoma, HepatocellularCarcinoma, Renal CellCASP8 and FADD-Like Apoptosis Regulating ProteinCell Line, TumorDown-RegulationDrug SynergismFemaleHumansKidney NeoplasmsLiver NeoplasmsAbietanesApoptosis Regulatory ProteinsBBC3 protein, humanBCL2L11 protein, humanBcl2l11 protein, mouseBcl-2-Like Protein 11CASP8 and FADD-Like Apoptosis Regulating ProteinDDIT3 protein, humanMembrane ProteinsPlant ExtractsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2Receptors, TNF-Related Apoptosis-Inducing LigandsalvinTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, humanTranscription Factor CHOP

Identifiers

PMID25596735
PMCPMC4359314
OpenAlexW1526360775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.